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Abstract
The Rho GTPase Rac1 activates the WAVE regulatory complex (WRC) to drive Arp2/3 complex-mediated
actin polymerization, which underpins diverse cellular processes. Here we report the structure of a WRC-
Rac1 complex determined by cryo-electron microscopy. Surprisingly, Rac1 is not located at the binding site
on the Sra1 subunit of the WRC previously identified by mutagenesis and biochemical data. Rather, it binds
to a distinct, conserved site on the opposite end of Sra1. Biophysical and biochemical data on WRC mutants
confirm that Rac1 binds to both sites, with the newly identified site having higher affinity and both sites
required for WRC activation. Our data reveal that the WRC is activated by simultaneous engagement of two
Rac1 molecules, suggesting a mechanism by which cells may sense the density of active Rac1 at membranes to
precisely control actin assembly.
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Abstract The Rho GTPase Rac1 activates the WAVE regulatory complex (WRC) to drive Arp2/3
complex-mediated actin polymerization, which underpins diverse cellular processes. Here we report
the structure of a WRC-Rac1 complex determined by cryo-electron microscopy. Surprisingly, Rac1
is not located at the binding site on the Sra1 subunit of the WRC previously identified by
mutagenesis and biochemical data. Rather, it binds to a distinct, conserved site on the opposite
end of Sra1. Biophysical and biochemical data on WRC mutants confirm that Rac1 binds to both
sites, with the newly identified site having higher affinity and both sites required for WRC
activation. Our data reveal that the WRC is activated by simultaneous engagement of two Rac1
molecules, suggesting a mechanism by which cells may sense the density of active Rac1 at
membranes to precisely control actin assembly.
DOI: https://doi.org/10.7554/eLife.29795.001
Introduction
Dynamic rearrangements of the actin cytoskeleton play central roles in cellular processes, ranging
from cell migration and adhesion to endocytosis and intracellular vesicle trafficking (Skau and
Waterman, 2015). In many of these processes, actin dynamics are spatially and temporally con-
trolled by members of the Wiskott-Aldrich Syndrome Protein (WASP) family. These proteins inte-
grate a diverse array of upstream signals and transmit them through their conserved VCA sequence
to the Arp2/3 complex, which, in turn, nucleates actin filaments to create branched actin networks at
membranes (Campellone and Welch, 2010; Padrick and Rosen, 2010). In most WASP family pro-
teins, the VCA element is inhibited in the resting state. Inhibition is mediated either by autoinhibition
within a single polypeptide chain, as in WASP and N-WASP, or by trans-inhibition within large multi-
protein assemblies, as in WAVE and WASH (Rotty et al., 2013). Multiple signals, including binding
to ligands (e.g. Rho family GTPases, phosphoinositide lipids and membrane receptors) and covalent
modifications (e.g. phosphorylation and ubiquitination), often act cooperatively to relieve inhibition
and concomitantly recruit WASP proteins to their sites of action at membranes (Chen et al., 2014a,
2010; Hao et al., 2013; Lebensohn and Kirschner, 2009; Padrick and Rosen, 2010;
Prehoda et al., 2000; Torres and Rosen, 2003; 2006).
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The WASP family members WAVE1, WAVE2 and WAVE3 are essential to actin dynamics needed
for normal development and function of most eukaryotic organisms, and are also implicated in many
cancers (Bisi et al., 2013; Lane et al., 2014; Takenawa and Suetsugu, 2007; Yanagisawa et al.,
2013). In cells, each WAVE protein functions exclusively within a 400 kDa, heteropentameric assem-
bly, termed the WAVE Regulatory Complex (WRC), which also contains the proteins Sra1, Nap1,
Abi2, and HSPC300 (or their homologs) (Stovold et al., 2005). Previously, we reported crystal struc-
tures of an inhibited WRC assembly containing all five subunits, but lacking the disordered C termi-
nus and SH3 domain of Abi2 and the proline-rich region of WAVE1 (mini-WRC) (Chen et al., 2010),
and of this assembly bound to a WRC Interacting Receptor Sequence (WIRS) motif peptide derived
from the adhesion receptor, protocadherin 10 (Chen et al., 2014a). The structure revealed that Sra1
and Nap1 form an elongated dimer of about 100  100 200 A˚. WAVE1, Abi2 and HSPC300 form a
trimer as an elongated 4-helix bundle, which aligns along the long axis of the Sra1/Nap1 dimer
(Figure 1A). Immediately following the helix bundle, an extended sequence of ~90 a.a. from WAVE1
‘meanders’ across the surface of Sra1 as a loose collection of loops and helices (the meander region).
The VCA element of WAVE1 is sequestered at the VCA-binding site by multiple interactions
between its V and C helices and a group of helices from both Sra1 and the meander region of
WAVE1 itself, explaining how WAVE1 is inhibited within the WRC (Chen et al., 2010).
The structures also suggested how the WRC might be activated and recruited to membranes by
the combined actions of the Rho GTPase Rac1, the acidic phospholipid PIP3, phosphorylation on
both Ser and Tyr residues, and membrane receptors containing WIRS motifs. Among these, the
GTPase Rac1 functions as a canonical activator, whose direct interaction with the WRC is necessary,
and in some reports, sufficient to drive activation (Chen et al., 2014a; Chen et al., 2010;
Eden et al., 2002; Ismail et al., 2009). Based on mutagenesis and biochemical data, we previously
proposed that Rac1 binds to a conserved surface at one end of Sra1 adjacent to the VCA-binding
site (referred to as the ‘A Site’ in Figure 1B). We hypothesized that binding of Rac1 could cause
eLife digest Our cells contain a network of filaments made up of a protein called actin. Just like
the skeleton that supports our body, the actin ‘cytoskeleton’ gives a cell its shape and strength.
Actin filaments are also critical for many other processes including enabling cells to move and
divide. The assembly of actin filaments must be properly controlled so that they are formed at the
right time and place within the cell.
A complex of proteins known as the WAVE Regulatory Complex (WRC) promotes the assembly
of actin filaments. The complex contains a region called the VCA, which is able to bind to and
activate another protein to make the new actin filaments. The WRC regulates filament assembly by
controlling the availability of the VCA in a way that is similar to opening and closing a safe box.
When new actin filaments are not needed, the safe box is closed and the VCA is not available.
However, when cells need to make new actin filaments, the WRC is opened to release the VCA
region so that it is able to bind to the filament-producing protein.
Previous studies have shown that a protein called Rac1 acts as a key to open the WRC and
trigger actin filament assembly. But it remains unclear how this works. A major obstacle to studying
this process is that Rac1 and the WRC only weakly interact with each other, which makes it difficult
to capture the interaction under experimental conditions.
To overcome this obstacle, Chen et al. tethered a Rac1 molecule to the WRC in order to make
the interaction more stable. A technique called cryo-electron microscopy was used to study the
three-dimensional shape of this Rac1-WRC complex. Unexpectedly, Rac1 was attached to a different
part of the WRC than the site predicted by previous studies. Further experiments showed that Rac1
needs to bind to both of these sites at the same time in order to open the WRC and release VCA,
similar to using two keys to open one safe box for increased security.
Some cancers, neurological disorders and other diseases can be caused by defects in WRC and
Rac1 activity. Therefore, these findings could lead to new ways to treat these conditions in human
patients.
DOI: https://doi.org/10.7554/eLife.29795.002
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structural changes that propagate through the meander region to the VCA to promote VCA release
and consequent activation toward the Arp2/3 complex (Chen et al., 2010). However, in the absence
of a WRC-Rac1 complex structure, it remained uncertain exactly how Rac1 binds to and activates the
WRC.
Here we report the structure of a WRC-Rac1 complex at 7 A˚ resolution determined by single-par-
ticle cryo-electron microscopy (cryo-EM), together with complementary mutagenesis and biochemi-
cal analyses of the complex. Surprisingly, Rac1 is not found on the binding site we predicted
previously. Rather, it binds to a conserved site on the opposite end of Sra1. Our biochemical data,
including quantitative pull-down, membrane recruitment, and analytical ultracentrifugation (AUC)
assays with WRC mutants, confirm that both the original site and the new site can bind Rac1, the lat-
ter with approximately 40-fold higher affinity. Actin assembly experiments further reveal that both
sites contribute to activation of the WRC toward the Arp2/3 complex. These data lead to a model in
which maximal WRC activation requires simultaneous engagement of two Rac1 molecules on the
membrane. This bivalent activation model suggests a mechanism by which cells may precisely con-
trol actin dynamics at membranes by sensing the density of active Rac1 produced by upstream sig-
naling pathways.
Figure 1. Cryo-EM structure of the WRC-Rac1 complex. (A) Schematic representation (left) and size-exclusion chromatography profile (right) of the
DWRC230-Rac1 complex, with Coomassie blue-stained SDS-PAGE gel of the peak fraction shown. Dashed line indicates the tethering sequence
between WAVE1 meander region and Rac1. (B) Overall EM density and the fitted model of the DWRC230-Rac1 complex. WAVE1(130–147, 161–230) and
(GGS)6 leading to Rac1 have no EM density and are shown as dotted lines. (C) Close-up views of Rac1 fitted into the extra density not accounted for by
the WRC. Black arrow heads indicate close contacts between Rac1 and the WRC.
DOI: https://doi.org/10.7554/eLife.29795.003
The following figure supplements are available for figure 1:
Figure supplement 1. A covalent DWRC230-Rac1 complex.
DOI: https://doi.org/10.7554/eLife.29795.004
Figure supplement 2. Representative EM images as well as class averages and 3D maps of the DWRC230-Rac1 complex.
DOI: https://doi.org/10.7554/eLife.29795.005
Figure supplement 3. Cryo-EM density map for the DWRC230-Rac1 complex.
DOI: https://doi.org/10.7554/eLife.29795.006
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Results
Engineering a stable WRC-Rac1 complex
Initially we sought to determine the crystal structure of an intermolecular complex of the WRC
bound to Rac1. Despite extensive efforts, however, we were unable to obtain diffracting crystals of
such an assembly. These investigations led us to an engineered WRC-Rac1 complex with improved
stability, which proved suitable for structure determination by cryo-EM (Figure 1A,B). Compared to
the mini-WRC construct previously used for crystallography (Chen et al., 2010), we incorporated the
following modifications to stabilize Rac1 binding (Figure 1A). First, we removed the VCA sequence
from the WRC (herein named DWRC), a modification that we previously showed increases the affinity
for Rac1 ~10 fold (Chen et al., 2010). Second, we genetically fused Rac1 to the C terminus of
WAVE1 (a.a. 1–230) through a flexible linker (GGS)6. The previous crystal structures (and the cryo-
EM structure reported here) showed that WAVE1 is only ordered to residue L184 within the WRC,
affording the system here an effective linker of 65 amino acids. This linker,~230 A˚ if fully extended,
would provide ample length to connect Rac1 to the previously demonstrated binding site, which is
approximately 70 A˚ from residue L184 of WAVE1. Based on experiments measuring binding to
immobilized GST-Rac1, the tethered Rac1 protected the WRC from binding to GST-Rac1 much
more efficiently than the un-tethered Rac1 protected the wild type WRC, suggesting the tethered
Rac1 binds the WRC in a physiologically relevant manner (Figure 1—figure supplement 1A). Third,
we introduced two point mutations, Q61L and P29S, into the fused Rac1. The Q61L mutation abol-
ishes the GTP hydrolysis activity of Rac1 (Der et al., 1986), maintaining the protein in the GTP-
bound state. The P29S mutation was identified as one of the major somatic mutations in melanoma
(Hodis et al., 2012; Krauthammer et al., 2012), and was shown to increase the affinity of Rac1 for
the effectors PAK1 (p21 protein activated kinase 1) and MLK3 (mixed-lineage kinase 3) (Hodis et al.,
2012; Krauthammer et al., 2012). Similarly, we found that the P29S mutation also increases the
affinity of Rac1 for the WRC (Figure 1—figure supplement 1B and C). Together, these optimiza-
tions facilitated stable association of Rac1 with the WRC. To distinguish this construct from the mini-
WRC used for crystallography, we name it the DWRC230-Rac1 complex.
Cryo-EM Structure of the DWRC230-Rac1 Complex
We first examined the DWRC230-Rac1 complex by electron microscopy of negatively stained speci-
mens, which showed images of monodisperse particles of homogeneous size and shape (Figure 1—
figure supplement 2A). This prompted us to collect cryo-EM images of vitrified samples for struc-
ture determination (Figure 1—figure supplement 2B). We first manually picked ~12,000 particles
from 489 images and calculated class averages using the iterative stable alignment and clustering
(ISAC) procedure (Yang et al., 2012). Some of the resulting averages showed extra density in addi-
tion to the WRC, indicating the presence of Rac1 (Figure 1—figure supplement 2C, arrows). We
further collected 1684 images, from which a total of 160,591 particles were automatically picked,
and then processed using Relion (Scheres, 2012). The pooled particle images were aligned to the
low-pass filtered crystal structure of the mini-WRC (PDB 3P8C) (Chen et al., 2010) and subjected to
3D classification (Figure 1—figure supplement 2D). After further refinement, we obtained a final
density map from 29,784 particles at a resolution of 7 A˚ (Figure 1—figure supplement 3).
The overall EM density map clearly revealed a structure containing both the WRC and Rac1 (Fig-
ure 1—figure supplement 3A), with Rac1 bound to Sra1 at one end of the WRC (detailed below).
The mini-WRC crystal structure (PDB 3P8C) could be unambiguously docked into the EM density
map, with the majority of the secondary structural elements fitting into the density without need for
adjustment (Figure 1B). Several surface loops in Sra1 and Nap1 that were not observed in the crystal
structure also have defined EM densities (Figure 2A). The EM map shows no density for the V and C
helices of the VCA region of WAVE1 (Figure 2B, right panel, elements colored black), which was
present in the mini-WRC crystal structure but was removed in the DWRC230-Rac1 complex used
here. No density was observed for the first helix (a1) of Sra1 (Figure 2B, left panel). In crystals of
mini-WRC this helix did not bind in intra-complex fashion, but rather to an adjacent WRC in the crys-
tal lattice. Density was also not observed for residues 161–230 of WAVE1 or the (GGS)6 linker
(Figure 2B, right panel), which leads to the N terminus of the fused Rac1, suggesting that this
sequence of 88 residues does not form a stable structure in the complex. No major conformational
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changes of the WRC were observed within the limits of our 7 A˚ resolution, except for the meander
region of WAVE1 (a.a. 90–184) (Figure 2C), which formed a series of helices (a2-a6) arrayed across
the surface of Sra1 in the mini-WRC crystal structure (Chen et al., 2010). In the EM map, the mean-
der region generally has weak density. Several regions either adopt an orientation different from the
crystal structure (a.a. 90–97 in a2, a.a. 113–118 prior to a3, and a.a. 148–160 between a5 and a6),
or have missing density (a.a. 130–147 between a3 and a5 and a.a. 161–182 of the long a6 helix)
(Figure 2C). In the crystal structure of the inhibited mini-WRC, helices a2 and a6 directly bind the V
and C regions of the VCA, respectively. Mutagenesis studies suggest that these interactions act
cooperatively to sequester the VCA, inhibiting its activity toward the Arp2/3 complex (Chen et al.,
2010). The observations here support this idea, since removing the VCA (and possibly Rac1 binding
as well) reciprocally appears to destabilize the meander region.
The only major extra density not accounted for by the WRC was located on a surface of
Sra1 ~120 A˚ from the previously proposed Rac1 binding site, on the opposite end of the long axis of
the WRC (Figure 1B). This density unambiguously accommodated the crystal structure of Rac1
Figure 2. Fitting of the WRC crystal structure to the EM density. (A) EM density for surface loops (represented by red dashed lines) missing in the mini-
WRC crystal structure. (B) Elements observed in the crystal structure but lacking densities in the EM reconstruction, with elements present in
the DWRC230-Rac1 construct in red and elements absent from the DWRC230-Rac1 construct in black. (C) Several structural elements (red) in the
meander sequence have EM densities suggestive of different orientations.
DOI: https://doi.org/10.7554/eLife.29795.007
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P29S, including all secondary structure elements and most loops (PDB 3SBD) (Krauthammer et al.,
2012) (Figure 1C). In this position, the N terminus of Rac1 is located ~100 A˚ from the last ordered
residue of WAVE1 to which it is linked, a distance that could readily be spanned by the 88 disor-
dered residues of the tether. Note that none of our EM maps resulting from 3D classification indi-
cated that Rac1 was bound to other regions of the WRC. Even supervised classification that included
as reference a model of the WRC with Rac1 bound to the previously predicted binding site failed to
produce a map that revealed additional density at this site (data not shown).
Rac1 and other small GTPases use two conserved structural elements, Switch I (a.a. 25–39) and
Switch II (a.a. 57–75), to bind and activate downstream signaling proteins in a nucleotide-dependent
manner (Mott and Owen, 2015). In our model of the complex, both Switch I and Switch II of Rac1
make direct contact with the WRC, through a conserved surface on the Sra1 subunit (a.a. 957–979,
arrow heads in Figure 1C). This observation further validates the EM density map, which was derived
without using crystal structures of Rac1 as a reference.
Rac1 binds to two distinct sites on the WRC with different affinities
In our structure Rac1 is not located at the site predicted by our previous biochemical/mutagenesis
analyses. That site is a conserved surface patch on Sra1 near the a4-a6 helices of the WAVE1 mean-
der region, adjacent to the VCA binding site (Figure 1B, Figure 3A) (Chen et al., 2010). Instead, in
the EM reconstruction, Rac1 binds to a different conserved surface at the opposite end of the rod-
shaped Sra1 subunit, which is distant from the meander-VCA region (Figure 1B, Figure 3A). For
clarity, here we name the previously described site the ‘A Site’ (for Adjacent Site), and the site
observed in the EM structure the ‘D Site’ (for Distant Site).
How can the previous biochemical analyses be reconciled with the location of Rac1 found in the
present structure? In our previous work, we found that the A Site was one of the few highly con-
served surface patches on the WRC. We showed that mutating any of three surface residues (C179R,
R190D, or M632D), or one pair of residues (E434K/F626A), at the A Site disrupted Rac1 binding in
qualitative GST pull-down experiments, and that the two mutations analyzed in a quantitative equi-
librium dialysis experiment (R190D and E434K/F626A) both decreased affinity (Chen et al., 2010). In
comparison, the D Site is also conserved, although less so than the A Site (Supplementary file 1
and Figure 3—figure supplement 1). To test if Rac1 also binds to the D Site, we introduced point
mutations to its surface residues and examined the mutants in a battery of assays. We divided the
surface into six distinct patches and mutated them separately (color coded in Figure 3B): P957A/
K958D/I959A, R961D/P963A/R964D, Y967A, G971W, E974A/F975A/H978A/Q979A, and D1122A/
E1123A. We also examined a point mutation, S969F, which is buried immediately beneath the D Site
(labeled in red in Figure 3C and D). The equivalent mutation, S968F, in Cyfip2 (the mouse ortholog
of Sra1) was shown to cause an altered cocaine response in mice through an unknown mechanism
(Kumar et al., 2013). Finally, we also reanalyzed a previously tested mutation at the A Site, C179R
(labeled in black in Figure 3A). As described in the Protein Purification section of the Materials and
Methods, all of the WRC mutants appear to be properly folded and assembled.
We first examined the ability of immobilized GST-Rac1 to retain the WRC mutants. GST-Rac1
loaded with GMPPNP (a poorly hydrolyzable GTP analog) could efficiently retain wild type (WT)
WRC as well as one of the six D Site mutants, D1122A/E1123A (Figure 3E). All other mutations at
the D Site substantially diminished binding, suggesting that this region mediates high-affinity inter-
actions with Rac1. The D1122A/E1123A mutation is located at the periphery of the D Site, likely
explaining its lack of effect on binding (Figure 3B, grey patch). Consistent with our previous report
(Chen et al., 2010), the A Site mutation, C179R, also decreased binding under the same experimen-
tal conditions, albeit more moderately (Figure 3E). The observed interactions are specific to active
Rac1, since Rac1-GDP did not bind to any of the WRCs (Figure 3—figure supplement 2A). The
S969F mutation did not appreciably affect binding (Figure 3E).
We obtained similar results under different reaction conditions, employing the high-affinity
mutant Rac1 (Q61L/P29S) at a higher salt concentration (100 mM NaCl, vs. 50 mM above) (Fig-
ure 3—figure supplement 2B). Under these conditions, which favor binding to the WRC, the A Site
mutation C179R, and the D Site mutations, P957A/K958D/I959A, G971W and E974A/F975A/H978A/
Q979A, all weakened binding to a moderate degree, whereas the R961D/P963A/R964D and Y967A
mutations at the D Site still eliminated observable binding. The D1122A/E1123A and S969F muta-
tions had no effect. These data suggest that the A Site makes a modest contribution to the total
Chen et al. eLife 2017;6:e29795. DOI: https://doi.org/10.7554/eLife.29795 6 of 22
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Figure 3. Rac1 binds to two distinct sites on the WRC. (A) Overall structure of the DWRC230-Rac1 complex showing the locations of the A site and D
site. Sra1 and Nap1 are shown in surface representation; WAVE1, Abi2, HSPC300 and Rac1 are shown in ribbon representation. Semitransparent pink
cylinders are used to refer to the positions of WAVE1 a6 helix (without observable EM density) and the V and C helices (only present in the mini-WRC).
Residues in the A Site whose mutation was previously shown to impair Rac1 binding are black. Surface patches in the D Site mutated here are colored
Figure 3 continued on next page
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observed binding in pull-down experiments, while the D Site, especially the surface patch formed by
R961/P963/R964/Y967, has a major contribution. It is notable that P963 and Y967 are highly con-
served in eukaryotic organisms including animals, fungi, amoebas and many protozoans, except
plants (Supplementary file 1). In the experiments below, we focused on the Y967A mutation to dis-
rupt the D Site.
Because Rac1 activates the WRC at membranes in vivo, we further developed an assay to exam-
ine if mutating the A or D Site could similarly disrupt the binding when Rac1 is attached to mem-
branes (Figure 3F). We fused an N-terminal mCherry tag and a C-terminal His8 tag to Rac1 (either
Q61L/P29S or wild type, as indicated in Figure 3F). The latter allowed the protein to be anchored
on supported bilayers containing 2% Ni2+-NTA-DGS lipid (see schematic presentation in Figure 3F)
(Banjade and Rosen, 2014). We then quantified the amount of EGFP-tagged WRC recruited to the
Rac1-containing membrane using Total Internal Reflection Fluorescence (TIRF) microscopy. Paralle-
ling the above GST pull-down experiments, mutating either the A Site (C179R) or the D Site (Y967A)
significantly decreased membrane recruitment of the WRC, with the D Site mutation having a larger
effect. In contrast, the S969F mutation did not decrease, but rather slightly increased membrane
recruitment (Figure 3F).
These data suggest that Rac1 can bind to both the A and D sites. Nevertheless, it remained possi-
ble that only the D Site directly contacts the GTPase (as observed in the cryo-EM structure) and the
A Site mutations disrupted binding through allosteric effects on the D site. To examine this possibil-
ity, we used Multi-Signal Sedimentation Velocity Analytical Ultracentrifugation (MSSV AUC) to
directly measure the stoichiometry of the interaction between Rac1 (Q61L/P29S) and DWRC230 (Fig-
ure 4) (Balbo et al., 2005; Padrick et al., 2010). To separately track sedimentation of the two com-
ponents, we fused EGFP to the N-terminus of Rac1. This labeling allowed us to use absorbance at
490 nm to specifically monitor EGFP-Rac1 and use interference signals to record the sedimentation
of all proteins. Thus, in our assay EGFP-Rac1 was tracked by both signals, and the WRC by interfer-
ence only. We note that MSSV AUC enables direct quantification of the EGFP-Rac1/WRC stoichiom-
etry for any given species, as well as its sedimentation coefficient. Individually, both EGFP-Rac1 and
the WRC sedimented as high-purity, monodisperse species, with sedimentation coefficients of 3.5 s
and 10.5 s, respectively (Figure 4, and see Figure 4—figure supplement 1 for SDS PAGE gels and
gel filtration chromatography profiles of the protein samples). When the two proteins were mixed,
keeping WRC at approximately 1 mM concentration and increasing EGFP-Rac1 from 1.2 mM to 15
mM, a fraction of EGFP-Rac1 began co-sedimenting with the WRC (Figure 4A, left panel, green
curves). Addition of EGFP-Rac1 also shifted the WRC peak toward a higher sedimentation coefficient
in a concentration dependent manner (Figure 4A, left panel, black curves). At an intermediate con-
centration of EGFP-Rac1 (3.7 mM), the WRC peak shifted to 11.7S with a Rac1:WRC stoichiometry of
1.3:1, suggesting more than one binding site. Increasing the concentration of EGFP-Rac1 up to 15.1
mM shifted the sedimentation coefficient of the WRC peak to 12.1S and stoichiometry to 1.9:1, con-
firming that two Rac1 molecules can simultaneously bind to a single WRC (Figure 4B).
Figure 3 continued
as in (B–F). (B) Close-up view of the D Site with semitransparent surface and key side chains shown under the surface. Rac1 was removed for clarity. (C–
D) top and side views of the D Site, showing the location of the buried residue S969 (red). (E) Coomassie blue-stained SDS-PAGE gel showing GST-
Rac1-GMPPNP (WT) pull-down assay of WRCs bearing the indicated mutations in Sra1 at the Rac1-binding sites. Top panel shows elution of material
retained on the beads, bottom panel shows input control. See non-equilibrium GST pull down assay section of Experimental Methods for details of
constructs. (F) Top: schematic of membrane recruitment assay using supported lipid bilayers. WRC construct was same as in panel E. Bottom:
quantification of the EGFP-WRC/mCherry-Rac1 signals for each reaction used 10 separate TIRF images, with five each collected from two independent
experiments. Error bars represent standard error, and p values were calculated by pairwise comparison using Tukey’s test (*p<0.05, and ****p<0.00005).
DOI: https://doi.org/10.7554/eLife.29795.008
The following figure supplements are available for figure 3:
Figure supplement 1. Surface conservation of the Sra1 subunit in the DWRC230-Rac1 complex (Rac1 removed for clarity), with a gradient of color from
green to white representing the most conserved surface residues (ConSurf score = 9) to the least conserved residues (ConSurf score = 1)
(Ashkenazy et al., 2010).
DOI: https://doi.org/10.7554/eLife.29795.009
Figure supplement 2. GST-Rac1 pull-down of different WRC mutants.
DOI: https://doi.org/10.7554/eLife.29795.010
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The MSSV AUC data for the mutants were quite different. For the A Site mutant (C179R), at a
nearly saturating concentration of EGFP-Rac1 (8.4 mM vs. dissociation constant KD of 0.27 mM as
determined below), the binding stoichiometry only reached 1:1 (Figure 4A, blue curves, 4B). For the
D Site mutant (Y967A), the binding stoichiometry only reached to 0.6:1 with 8.5 mM Rac1, consistent
with the lower affinity (KD ~11.5 mM) of the A Site as determined below (Figure 4A, red curves, 4B)
and implicated by the qualitative GST-pull down data above. Together, the AUC data confirmed
that two molecules of Rac1 can engage the WRC at the A and D sites simultaneously, and that our
mutations could selectively weaken binding to the individual sites.
The above data all suggest that the A Site has a weaker affinity than the D Site. To quantify this
difference, we used an equilibrium pull-down (EPD) assay to determine the binding affinity of GST-
Rac1 (Q61L/P29S) for each site (Figure 5) (Lee et al., 2000; Pollard, 2010). In this assay, we mixed
a constant amount of DWRC230 (0.1 mM) with varying concentrations of GST-Rac1 (0.01 mM to 140
mM) and a fixed amount of Glutathione Sepharose beads. The beads were sufficient, given their
quantity and the extremely high affinity of GST for glutathione (KD ~7 pM, [Waterboer et al., 2005])
to retain virtually all GST-Rac1 and its bound WRC, even at the highest concentrations (Figure 5—
figure supplement 1). After a brief centrifugation to pellet the beads, uncomplexed WRC remained
in the supernatant and could be quantified by SDS PAGE (example gels shown in Figure 5A),
Figure 4. Stoichiometry of the Rac1/WRC complex determined by analytical ultracentrifugation. (A) Sedimentation profiles (ck(s) distributions) of
indicated samples at various concentrations (green for EGFP-Rac1 (Q61L/P29S), black for WT DWRC230, blue for C179R, and red for Y967A). Dashed
lines are used as a reference to indicate the sedimentation coefficients of the WRC alone and EGFP-Rac alone, respectively. (B) Sedimentation
coefficient and stoichiometry of Rac1/WRC in the WRC peak.
DOI: https://doi.org/10.7554/eLife.29795.011
The following figure supplement is available for figure 4:
Figure supplement 1. Gel filtration chromatography profiles and Coomassie blue-stained SDS-PAGE gels of the DWRC230 and the EGFP-Rac1
samples used in the AUC experiments.
DOI: https://doi.org/10.7554/eLife.29795.012
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Figure 5. Quantification of the binding affinity by equilibrium pull-down assay. (A). Representative Coomassie-blue-stained SDS-PAGE gels of the
supernatant samples in equilibrium pull down experiments involving GST-Rac1 (Q61L/P29S) binding to DWRC230. (B) Schematic representation of the
three successful equilibrium models used to fit the binding isotherms. (C) Binding isotherms fit to the indicated models. For WT and C179R DWRC230,
results for single-site (dotted curves) and two-site (solid curves) models are shown. For Y967A WRC, results for single-site (dotted curves) and GST-
dimer models (solid curves) are shown. The data were pooled from multiple independent experiments (5 experiments for WT and C179R, and 2
experiments for Y967A) covering various concentration ranges. Derived dissociation constants are shown in the right table, with KD,D representing the
dissociation constant for the D Site, KD,A for the A Site, KD,A(D) for the A Site when the D Site is occupied by Rac1, and KD,A’ for the A Site of the
second WRC in the GST-dimer model. Standard errors of the fit for the derived KD values are shown. p values were obtained by F-test; the most
appropriate dissociation constants based on the p values are shown in bold. See Figure 5—figure supplement 2 and Methods for additional details.
DOI: https://doi.org/10.7554/eLife.29795.013
The following figure supplements are available for figure 5:
Figure supplement 1. Representative Coomassie blue-stained SDS-PAGE gels of the supernatant (top gel) and the beads samples (bottom gel) in an
equilibrium pull-down assay involving GST-Rac1 (Q61L/P29S) binding to DWRC230.
Figure 5 continued on next page
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allowing us to determine the binding isotherms, which we could numerically fit to different binding
models to obtain dissociation constants (Figure 5B and Figure 5—figure supplement 2). Note that
the binding isotherms determined by the EPD assays do not distinguish the WRC species with one
or two bound Rac1 molecules, or the WRC species with Rac1 bound to the D-Site or the A-Site,
because all species can be equally pelleted with the glutathione beads. Therefore, fitting the binding
isotherm of the WT WRC to a cyclic two-site binding model (Figure 5—figure supplement 2A) to
extract the dissociation constants for both the D Site and the A Site could not converge, with large
uncertainty for the derived KD (not shown). Fitting to a simplified sequential two-site binding model
or to a single-site model resulted in a similar dissociation constant for the D Site (KD,D of
0.169 ± 0.008 mM in Figure 5C, black solid curve compared to 0.106 ± 0.002 mM in Figure 5C, grey
dotted curve). Fitting to the sequential two-site binding model was statistically better than the sin-
gle-site model (p=5.4510 9), and yielded a dissociation constant for the A Site for the D Site-
bound WRC (KD,A(D)) of 0.262 ± 0.044 mM, suggesting positive cooperativity between the A and D
Sites compared to the dissociation constant for the A Site alone (KD,A of 11.52 ± 0.11 mM as deter-
mined below). Such cooperativity likely results from avidity, as two nearby Rac1 molecules, either
partners in a GST fusion or adjacent on the solid matrix, bind the same WRC.
In contrast to the WT WRC, the isotherm for the A Site mutant (C179R), fit well to a single-site
binding model, yielding a KD,D of 0.265 ± 0.004 mM for the D Site (Figure 5C, light blue dotted
curve), whereas fitting to a two-site binding model resulted in an identical KD,D with no statistical
improvement (Figure 5C, blue solid curve), supporting the idea that the C179R mutation effectively
impaired the A Site.
For the D Site mutant (Y967A), the strong shift of the data to higher Rac1 concentrations clearly
shows that the interaction that recruits the WRC to the beads is appreciably weaker than that for the
wild type or A site mutant WRCs. But the isotherm did not fit well to either a single- or a two-site
binding model, although both yielded a similar KD,A for the A Site (10.85 ± 0.4 vs 9.6 ± 0.38 mM,
Figure 5C red dotted curve, and see Figure 5—figure supplement 2). More complicated models
involving more than two dissociation constants did not converge (not shown). However, when we
modeled a dimeric GST-Rac1 binding two WRCs cooperatively (Figure 5B, GST-dimer model), the
fitting was significantly improved (p=1.3910 11, Figure 5C, red solid curve). This model yielded a
KD,A of 11.52 ± 0.11 mM for binding of the first WRC, and a KD,A’ of 0.033 ± 0.003 mM for binding
of the second WRC to this initial (GST-Rac1)2-WRC assembly. These data would be consistent with
strong positive cooperativity between WRC binding events when Rac1 only binds to the A Site. The
better fit afforded by this model does not authenticate the molecular mechanism it describes. We
note, however, that the potential for cooperative interactions between closely-positioned WRCs has
been suggested by the crystal structure of miniWRC. There, the N-terminal helix of Sra1, which is
not observed in the EM density of the dilute WRC studied here, bound between adjacent WRC
assemblies in the crystal lattice (Chen et al., 2010). Future studies to examine such an interaction
and its functional significance may be revealing. The GST-dimer model was not statistically better
than the best fits for the WT or C179R WRC (Figure 5—figure supplement 2B; Figure 5—figure
supplement 2C, thin solid curves).
In summary, our data demonstrate that both the previously identified A Site and the newly identi-
fied D Site are bona fide binding sites for Rac1, the latter with ~40 fold higher affinity than the for-
mer. The two sites can act together to recruit the WRC to membranes containing active Rac1. In
retrospect, in our previous equilibrium dialysis experiments, the A Site mutants did not reach satura-
tion at the highest concentrations of Rac1 used (8 mM), behavior we interpreted as indicating
reduced affinity at a single site (see Figure 3B of [Chen et al., 2010]). Our new data provide a new
interpretation for this observation, suggesting that the A Site mutants might have approached an
asymptote at ~50% of the level reached by the WT WRC (i.e. with one site effectively eliminated by
the mutation and a second site intact).
Figure 5 continued
DOI: https://doi.org/10.7554/eLife.29795.014
Figure supplement 2. Quantification of the binding affinity by equilibrium pull-down assay involving GST-Rac1 (Q61L/P29S) bindingDWRC230.
DOI: https://doi.org/10.7554/eLife.29795.015
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Both Rac1-Binding sites contribute to WRC activation
We next asked whether both Rac1-binding sites are important for activating the WRC toward the
Arp2/3 complex in pyrene-actin assembly assays (Figure 6). In these assays, actin assembly (moni-
tored by an increase in fluorescence of pyrene-labeled actin) occurs slowly and with a long initial lag
in the presence of WRC230VCA and Arp2/3 complex alone (orange curve in Figure 6A). Addition of
Rac1 (Q61L)-GMPPNP activates the WRC, which, in turn, stimulates the actin-nucleating function of
the Arp2/3 complex, decreasing the lag and increasing the maximum rate of actin assembly (dashed
curves in Figure 6A).
For the WT WRC, a saturating concentration of Rac1 (10 mM) could produce actin-assembly rates
equivalent to that of the constitutively active WAVE1 VCA peptide (dashed cyan curve in
Figure 6A). Mutating the D Site (Y967A, Figure 6B,E) or the A Site (C179A, Figure 6D,E)
completely abrogated activation, suggesting that activation of the WRC requires binding of Rac1 to
both sites. Interestingly, the S969F mutant, which had slightly higher affinity for Rac1 (Figure 3F),
was more sensitive to the GTPase than was WT WRC (Figure 6A,C,E). For example, the S969F
mutant WRC was fully activated by only 3 mM Rac1, instead of 10 mM (green dashed curve in
Figure 6C vs. cyan dashed curve in Figure 6A). Similarly, 1 mM Rac1 plus the S969F mutant WRC
produced actin-assembly rates equivalent to 3 mM Rac1 plus the WT WRC (magenta dashed curve in
Figure 6C vs. green dashed curve in Figure 6A). These data suggest that both Rac1-binding sites
are important for activation of the WRC.
To further examine this notion, we re-analyzed the actin assembly data for Rac1 Q61L/
P29S + WRC shown in Figure 1—figure supplement 1C in light of the dissociation constants
derived from the EPD assays. As shown by the black data in Figure 6F, actin assembly rate is
strongly non-linear with the total concentration of Rac1-bound WRC species, i.e. the sum of both
WRC-(Rac1)1 complexes (A or D site engaged) and WRC-(Rac1)2. The lack of response to WRC-Rac1
concentrations up to 80 nM suggests suggests that engagement of a single site (primarily the D Site,
due to its high affinity) is not sufficient to drive WRC activation. Further, plotting actin assembly rate
versus the concentration of WRC-(Rac1)2 yields a linear relationship (red data in Figure 6F). The
slope of this line gives a specific activity of ~0.22 nM actin/s/nM WRC-(Rac1)2. Together, the qualita-
tive and quantitative actin assembly data show that engagement of both the A and D sites is neces-
sary for WRC activation.
Discussion
The Rho family GTPase, Rac1, plays important roles in directing signals from upstream pathways to
the WRC to promote actin cytoskeletal assembly. We have determined the structure of a WRC-Rac1
complex using cryo-EM, revealing a GTPase-binding site distinct, and physically distant, from the
site indicated previously by mutagenesis. Nevertheless, several lines of biochemical data demon-
strate that both sites do, in fact, bind Rac1. Moreover, both are required for activation of the WRC
toward the Arp2/3 complex. These findings have several important implications.
First, Rac1 activates the WRC through two binding sites that are distinct from the VCA-binding
surface of Sra1. We previously posited that binding to the A Site might trigger conformational
changes in the adjacent meander region. These, in turn, could destabilize the meander-VCA con-
tacts, leading to release of the VCA from the body of the WRC (Chen et al., 2010). Such a mecha-
nism, involving destabilization of a VCA-containing structural element, would be analogous to the
activation of the WAVE1 relatives WASP and N-WASP by the Rho family GTPase Cdc42 (Kim et al.,
2000; Prehoda et al., 2000; Torres and Rosen, 2003). Our current data suggest that the A Site and
the D Site likely cooperate to trigger conformational changes that release the VCA. These changes
may be focused in the meander region, as in our initial hypothesis, or may involve more substantial
rearrangements of the WRC body, as suggested by the large distance between the D Site and the
VCA-meander element of the assembly. In the latter scenario, the requirement for engagement of
Rac1 at both sites to activate the WRC may explain why we did not observe major conformational
changes on the WRC in our current structure, in which only the D Site is occupied. It remains to be
understood how Rac1 binds the A Site and how the A and D Sites cooperate to drive allosteric acti-
vation of the WRC.
Second, our data inform on the recent observation that a point mutation, S968F, in Cyfip2 (corre-
sponding to S969F in Sra1) caused phenotypes in mice including decreased response to cocaine and
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Figure 6. Activation of the WRC requires both Rac1-binding sites. (A–D) Actin assembly assays of the wild-type WRC230VCA (A), Sra1 Y967A (B), Sra1
S969F (C), and Sra1 C179R (D), with corresponding reaction conditions shown on the right. Reactions contain 4 mM actin (5% pyrene labeled), 10 nM
Arp2/3 complex, 100 nM WRC230VCA or VCA, and indicated amount of Rac1 Q61L loaded with GMPPNP. (E) Maximum actin assembly rates at
different Rac1 concentrations derived from data in (A–D) (Doolittle et al., 2013). (F) Maximum actin assembly rates at different concentrations of
distinct WRC-Rac1 species, obtained from the data shown in Figure 1—figure supplement 1C for WRC activation by Rac1 Q61L/P29S. Concentrations
of the indicated species of WRC-Rac1 complexes (shown as cartoons) formed at different Rac1 concentrations in the actin assembly assay were
calculated using DynaFit (Kuzmic, 1996) by using a two-site cyclic model shown in Figure 5—figure supplement 2A, using KDD of 0.265 mM and KDA
of 11.52 mM (derived from Figure 5, assuming no cooperativity between the A and D Site, since the actin assembly assays were performed in solution).
Black data plot the summed concentration of all WRC-Rac1 species, while red data plot only WRC-(Rac1)2. A linear fit of the latter data yields r
2 of 0.98.
DOI: https://doi.org/10.7554/eLife.29795.016
The following figure supplement is available for figure 6:
Figure supplement 1. Gel filtration chromatography profiles of the WRC230VCA samples used in the actin assembly assays.
DOI: https://doi.org/10.7554/eLife.29795.017
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a reduced number of dendritic spines in neurons of the nucleus accumbens (Kumar et al., 2013).
We found that S969 in Sra1 is buried immediately underneath the D Site. Unlike the previous
hypothesis that this mutation may act by destabilizing the WRC, our results show that S969F in Sra1
facilitates Rac1 binding and WRC activation. It is possible that S969 may be part of the pathway for
the conformational propagation from the D Site to the VCA-binding pocket upon Rac1 binding.
Assuming the S968F mutation in Cyfip2 has a similar biochemical effect, our data suggest that exces-
sive activation of the WRC by Rac1 might be responsible for the observed changes in cocaine
response and neuronal morphology.
Third, our data depict how Rac1 could work together with other signaling molecules to regulate
the WRC on membranes (Figure 7).One face of the WRC is highly basic, and the opposite face is
highly acidic (Chen et al., 2010). This charge distribution suggests that when the WRC is bound to
the negatively charged inner leaflet of the plasma membrane, and/or specific phospholipids such as
PIP3, its basic surface will lie against the membrane and its acidic surface will face the cytoplasm. In
this orientation, both Rac1 binding sites can be positioned to enable a bound GTPase to bury its
prenylated tail in the bilayer, consistent with an activation model involving simultaneous engagement
of both sites. This orientation is also compatible with other potential interactions. For example, VCA
can be readily released from above the membrane to interact with the Arp2/3 complex further in the
cytoplasm (Chazeau et al., 2014). In addition, WIRS-containing transmembrane receptors could
reach the WIRS-binding site on the acidic face of the WRC through < 23 residues (or ~80 A˚ in dis-
tance; Figure 7A) (Chen et al., 2014a). Indeed, with few exceptions, the WIRS elements in previ-
ously predicted WIRS-containing receptors in humans are generally located > 25 residues from their
transmembrane sequence (not shown) (Chen et al., 2014a). These restraints together suggest a
plausible model showing how the WRC may be oriented at membranes to interact with various regu-
latory molecules.
Finally, our bivalent interaction model provides an appealing mechanism to explain how cells
could sense the level of active Rac1 at membranes to spatially and temporally control WRC activa-
tion and actin polymerization. Our data suggest that WRC activation requires simultaneous engage-
ment of two Rac1 molecules at two distinct binding sites with ~40 fold different affinity. When the
Figure 7. Two Rac1 molecules bind to the WRC on the membrane. Surface representation (A) and surface charge representation (B) (calculated using
APBS in Pymol) (Dolinsky et al., 2007) show how the WRC can be oriented on the membrane to simultaneously interact with multiple signaling
molecules, including two Rac1 molecules (gold and orange) anchored on the membrane through prenylation of their C-terminal tails, WIRS-containing
surface receptors (dark blue), and acidic phospholipids through electrostatic interaction (represented by membrane). The Rac1 at the D site is taken
from the DWRC230-Rac1 complex structure determined here; Rac1 at the A site was manually docked in a plausible orientation to contact Sra1 residues
179, 190, 434, 626 and 632 and place the C terminus near the membrane. WIRS-containing receptors could approach the WRC from the back (shown)
or the front (not shown).
DOI: https://doi.org/10.7554/eLife.29795.018
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density of Rac1 at membranes is low, Rac1 should interact with the WRC preferentially through the
high-affinity site, which on its own is not sufficient to trigger activation but primes the complex. The
WRC only becomes activated when Rac1 density is sufficient to enable binding to both sites. Conse-
quently, activation of the WRC at membranes is likely non-linear with respect to Rac1 density (note
that technical limitations in working with low Rac1 density on membranes prevented us from examin-
ing this experimentally). This behavior could be harnessed by cells to determine precisely where and
when to turn on actin assembly. Analogous ideas have been suggested previously, based on obser-
vations that Rac1 and the Arf GTPase can cooperatively recruit and activate the WRC at membranes
(Koronakis et al., 2011). Given the low sequence homology between Rac1 and Arf (22% and 38%
identity in Switch I and Switch II, respectively), we feel it is unlikely that either the A or D site that we
have characterized is also the binding site for Arf. Further, these cooperative effects could modulate
the actions of other WRC ligands. For example, we previously discovered a large array of WIRS-con-
taining receptors, which could potentially recruit the WRC to membranes (Chen et al., 2014a). For a
given receptor, whether the recruitment would lead to productive activation of the WRC and actin
polymerization would depend on the local membrane density of active Rac. Other regulators of the
WRC, including kinases, acidic phospholipids and scaffolding proteins, might also cooperate with
Rac1 activation in similar fashion (Chen et al., 2010; Lebensohn and Kirschner, 2009; Miki et al.,
2000; Padrick et al., 2011). Moreover, the unstructured regions of WAVE and Abi (including the C
terminal SH3 domain of Abi), which are not included in our current construct, may make additional
contributions to Rac1 binding and activation. These regions have been shown to be important ele-
ments for regulating WRC activity, primarily by recruiting other regulatory molecules through inter-
actions mediated by poly-proline sequences and/or SH3 domains (Chen et al., 2014c; Dai and
Pendergast, 1995; Miki et al., 2000; Soderling et al., 2002) or by other mechanisms yet to be
understood (Miyamoto et al., 2008). Together, these effects would lead to precise control of the
timing and degree of actin assembly depending on the specific collection of upstream signals and
their spatial organization at the membrane.
Materials and methods
Protein purification
Similar to mini-WRC, all WRC constructs used in this work contain human Sra1, Nap1, HSPC300 (or
EGFP-HSPC300), and Abi2 (1-158), in addition to different WAVE1 constructs, including WAVE1(1–
230)-(GGS)6-Rac1(1-177)(Q61L/P29S) in DWRC230-Rac1, WAVE1(1–217) in DWRC217, WAVE1(1–
230) in DWRC230, WAVE1(1–217)-(GGS)6-(485-559) in WRC217VCA, and WAVE1(1–230)-(GGS)6-
(485-559) in WRC230VCA. The WRCs were expressed and purified essentially as previously
described for the mini-WRC (Chen et al., 2010; Ismail et al., 2009), except that the MBP-tagged
WAVE1 proteins were expressed in ArcticExpressTM (DE3)RIL cells (Stratagene) at 10˚C (Chen et al.,
2014b).
Based on the following arguments the mutant WRCs all appear to be properly assembled and
stable. (1) All mutations were made to surface residues, except the S967F mutation, which is buried
immediately underneath the D Site (and nevertheless did not negatively affect Rac1 binding/activa-
tion). Such mutations likely only disrupt the local binding surface, rather than the overall folding of
the WRC, especially since the WRC is ~400 kDa in size and is held together through multiple, exten-
sive inter-subunit interactions. (2) Reconstitution of the recombinant WRC is a multi-step process,
involving purification of individual proteins from different host cells and assembly/purification of sub-
complexes and ultimately the WRC by a variety of affinity, ion exchange and gel filtration chroma-
tography steps. All the mutant WRCs behaved identically to the wild type WRC during each step of
the reconstitution (see example in Figure 4—figure supplement 1 top panel, and Figure 6—figure
supplement 1, comparing gel filtration chromatography profiles of mutant WRCs to the wild type).
Furthermore, the C179R and Y967A mutants, each at a distinct Rac1 binding site, behaved identi-
cally to the wild type WRC in the MSSV AUC experiments. A mutation that disrupts the overall fold-
ing would very likely cause aberrant behaviors during certain steps in reconstitution, leading to
lower purity and yield, or complete failure of reconstitution.
MBP-tagged mCherry-(GGS)6-Rac1(1-188)-His8 (mCherry-Rac1-His8 for short) and MBP-tagged
mEGFP-(GGS)6-Rac1(1-188) (EGFP-Rac1 for short) were expressed in BL21 (DE3) T1
R cells at 18˚C
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overnight and purified using amylose beads (New England Biolabs). After the MBP tag was removed
by TEV-protease cleavage, the protein was further purified by Ni-NTA agarose beads
(Qiagen, Germany), followed by cation-exchange chromatography through a Source SP15 column
(GE Healthcare). All constructs were verified by DNA sequencing. Other proteins, including Arp2/3
complex, actin, WAVE1 VCA, GST-Rac1, Rac1 and TEV protease, were purified as previously
described (Ismail et al., 2009).
Electron microscopy
Prior to the EM experiments, an aliquot of the purified DWRC230-Rac1 complex was thawed and
passed through a 2.4 mL Superdex 200 gel-filtration column (GE Healthcare) to remove glycerol
from previous purification steps and exchange buffer to 10 mM HEPES pH 7.0, 100 mM NaCl, 1 mM
MgCl2 and 2 mM TCEP. The protein sample (3.5 ml at 0.1 mg/mL) was applied to glow-discharged
Quantifoil holey carbon grids (400 copper mesh, R1.2/1.3), which were then flash frozen in liquid eth-
ane using a Gatan CryoPlunge 3. Grids were imaged with an FEI Tecnai F20 operated at an accelera-
tion voltage of 200 kV and a calibrated magnification of 40,410x (nominal magnification of 29,000x),
yielding a pixel size of 0.62 A˚ on the specimen level. A Gatan K2 Summit direct detector device
(DDD) camera was used to collect dose-fractionated image stacks in super-resolution counting
mode using the UCSF Figure 4 data acquisition software (Li et al., 2013). The dose rate used was
6.4 e–/A˚2/s. Of a total of 2173 image stacks, 30 frames were recorded with 200 ms per frame (total
exposure time of 6 s) for 1366 stacks, 34 frames were recorded with 300 ms per frame (total expo-
sure time of 10.2 s) for 407 stacks, and 51 frames were recorded with 200 ms per frame (total expo-
sure time of 10.2 s) for 400 stacks. The frames were binned over 2  2 pixels (yielding a pixel size of
1.24 A˚), aligned to each other using motioncorr (Li et al., 2013), and summed.
Image processing
The defocus parameters of each micrograph were determined with CTFFIND3 (Mindell and Grigor-
ieff, 2003). Particles from the first 489 images were manually picked using e2boxer (Tang et al.,
2007) and windowed into 220  220 pixel images, which were then reduced to 64  64 pixel
images. The 11,874 particle images were subjected to the iterative stable alignment and clustering
(ISAC) procedure (Yang et al., 2012) implemented in SPARX (Hohn et al., 2007). Three ISAC gener-
ations, specifying 200 particles per group and a pixel error threshold of 0.7, resulted in classification
of 2607 particles (~22% of the entire data set) into 56 classes.
All images were then automatically picked with Relion1.3 (Scheres, 2012), yielding 160,591 par-
ticles that were windowed into 250 250 pixel images. The particle images were subjected to 2D clas-
sification specifying 300 classes, and classes producing poor averages were discarded. This step was
repeated specifying 200 classes. The remaining 78,406 particles were subjected to 3D classification
specifying 12 classes and using as initial model the crystal structure of the mini-WRC (PDB 3P8C)
(Chen et al., 2010) low-pass filtered to 60 A˚. Six classes showing extra density for Rac1 (39,145 par-
ticles) were combined and subjected to a second round of 3D classification specifying 10 classes. Of
the resulting maps, 8 classes showed extra density for Rac1 (Figure 1—figure supplement 2D) and
were combined (29,784 particles) for refinement, yielding a map at a resolution of 7.4 A˚.
For particle polishing in Relion (Scheres, 2012), image stacks were created for which each frame
represented 600 ms of exposure. For instance, for image stacks recorded with 200 ms frames, 3
frames were averaged; for image stacks recorded with 300 ms frames, 2 frames were averaged.
Only the first 10 frames, corresponding to an exposure time of 6 s, were used for particle polishing.
The final map had a resolution of 7.0 A˚, as estimated by Fourier shell correlation of independently
refined 3D reconstructions from half data sets using the 0.143 cut-off criterion (Figure 1—figure
supplement 3B). The local resolution was assessed using the program ResMap (Kucukelbir et al.,
2014) (Figure 1—figure supplement 3C). Atomic models of the mini-WRC (PDB 3P8C) and Rac1
(PDB 3SBD) were docked into the EM map using UCSF Chimera (Pettersen et al., 2004). Figures
were prepared with UCSF Chimera and Pymol (Schrodinger, 2015). The EM density map has been
deposited in EMDB with accession number EMD-6642.
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Non-equilibrium GST Pull-down assay
Non-equilibrium GST pull-down experiments in Figure 3E were performed as previously described
(Chen et al., 2014a). Briefly, 130 pmol of GST-Rac1(1-177)-GMPPNP and 260 pmol of WRC (com-
posed of Sra1, Nap1, MBP-EGFP-HSPC300, MBP-Abi2(1-158) and MBP-WAVE1(1–230)) were mixed
with 20 mL of Glutathione Sepharose beads (GE Healthcare) in 1 mL of binding buffer (20 mM HEPES
pH 7, 50 or 100 mM NaCl, 5% (w/v) glycerol, 2 mM MgCl2 and 5 mM b-mercaptoethanol) at 4˚C for
30 min, followed by three washes using 1 mL of the binding buffer. Bound proteins were eluted with
GST elution buffer (100 mM Tris-HCl pH 8.5, 50 mM NaCl, 5% (w/v) glycerol, 2 mM MgCl2, 5 mM b-
mercaptoethanol and 30 mM reduced glutathione) and examined by SDS-PAGE. Figure 3—figure
supplement 2A and B used GST-Rac1(1-177)-GDP and GST-Rac1(1-177) (Q61L/P29S), respectively
and the same WRC assemblies as Figure 3E.
Equilibrium GST pull-down assay
Equilibrium GST pull-down (EPD) experiments were performed essentially as previously described
(Lee et al., 2000; Pollard, 2010). Glutathione Sepharose beads (GE Healthcare) were first equili-
brated in EPD buffer (20 mM HEPES pH 7, 100 mM NaCl, 5% (w/v) glycerol, 2 mM MgCl2, and 5
mM b-mercaptoethanol) and stored as a 50% (v/v) slurry. All protein samples were dialyzed against
EPD buffer overnight at 4˚C to maximize buffer match. After dialysis, GST-Rac1(1-188) (Q61L/P29S)
was concentrated to ~500 mM using an Amicon Ultra centrifuge concentrator (3 kDa MWCO, Milli-
pore). All proteins were centrifuged at ~21,000 g at 4˚C for 10 min to remove denatured proteins
before use. Each reaction was assembled in 100 mL total volume of EPD buffer in a 200 mL PCR tube
(Axygen), which contained 0.1 mM DWRC230 (consisting of Sra1, Nap1, HSPC300, MBP-Abi2(1-158)
and MBP-WAVE1(1–230)) varying concentrations of GST-Rac1(1-188) (Q61L/P29S), 30 mL of the Glu-
tathione Sepharose beads (by aliquoting 60 mL of the 50% (v/v) slurry using a wide-bore pipette tip),
and 0.05% Triton X100 to facilitate mixing. The reactions were gently mixed at 4˚C on a rotary mixer
for 30 min. After a brief centrifugation (~10,000 g for 30 s) to pellet the beads, 40 mL of the superna-
tant was immediately transferred to 8 mL of 6X loading buffer (360 mM Tris-HCl pH 6.8, 12% (w/v)
SDS, 60% (w/v) glycerol, 0.00012% (w/v) bromophenol blue, and 140 mM freshly added 2-mercap-
toethanol), and analyzed by Coomassie blue-stained SDS-PAGE gels. The gels were imaged by a
ChemiDocTMXRS + system (BioRAD) using its standard protocols. Total intensity of the Sra1 and
Nap1 bands was quantified by ImageJ (FIJI) to determine the unbound WRC. The derived fractional
occupancy from 2 to 5 independent experiments was directly merged to obtain the binding iso-
therms. The program DynaFit (BioKin [Kuzmic, 1996]) was used to numerically fit the binding iso-
therms to different equilibrium models to obtain dissociation constants KD (see Supplementary file
2 for scripts). The uncertainty of the derived KDs was further evaluated by Monte Carlo simulations
with a ‘shuffle’ algorithm implemented in DynaFit. The final KD values reported in Figure 5 together
with the standard errors of the fit were determined by the histograms generated by 5,000 Monte
Carlo simulations (Kuzmic, 1996). The fitting results were compared by the F-test using Matlab
(Mathworks).
Membrane recruitment assay
Supported lipid bilayers (SLBs) containing 98% POPC and 2% Ni2+-NTA DGS (Avanti Polar lipids)
were prepared as previously described (Banjade and Rosen, 2014; Su et al., 2016), with the follow-
ing modifications. After washing with 5% Hellmanex III (He¨lma Analytics), glass bottom 96-well plates
(Matrical) were washed with 6 M NaOH for 30 min at 45˚C twice, and thoroughly rinsed with MilliQ
H2O. Small unilamellar vesicles (SUVs) were added to cleaned wells equilibrated with 50 mM HEPES
pH 7.5, 150 mM NaCl and 1 mM TCEP, and incubated at 40˚C for 1 hr.
The membrane recruitment assay was performed at room temperature. The SLBs were first
washed twice with binding buffer containing 10 mM HEPES pH 7.0, 100 mM NaCl, 2 mM MgCl2, 1
mM TCEP and 1 mg/mL BSA. mCherry-Rac1-His8 protein (either Q61L/P29S or wild type, as indi-
cated in Figure 3F) was added at 20 nM concentration, and allowed to bind the lipid bilayers for 30
min. Unbound proteins were then removed by three washes, which together afforded a 125-fold
dilution of the initial solution. EGFP-tagged WRCs (composed of Sra1, Nap1, MBP-EGFP-HSPC300,
MBP-Abi2(1-158) and MBP-WAVE1(1–230)) were then added at 80 nM and incubated for 30 min,
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followed by three washes affording a 125-fold dilution of the initial solution to reduce non-specific
binding of the WRC as well as background fluorescence.
TIRF images were taken using a TIRF/iLas2 module (Biovision) mounted on a Leica DMI6000
microscope with a 100  1.49 NA objective (EM-CCD camera, ImagEMX2, Hamamatsu). Images
were acquired at 488 nm for EGFP-WRC and 561 nm for mCherry-Rac1. Images were processed
using ImageJ (FIJI). Signal from the 488 nm channel from samples with only mCherry Rac1 and bind-
ing buffer was used as background for EGFP-WRC measurements. Signal from the 561 nm channel
from samples with only SLBs and EGFP-WRC was used as background for mCherry-Rac1 measure-
ments. EGFP/mCherry signals were calculated from 10 images from two independent experiments.
Data are reported as mean ± SEM. The autofocus module on our microscope was used to find the
focal plane for all measurements.
Analytical Ultracentrifugation
The Multi-Signal Sedimentation Velocity (MSSV) Analytical Ultracentrifugation (AUC) assay was per-
formed as previously described (Balbo et al., 2005; Padrick et al., 2010), to measure the stoichiom-
etry of binding between EGFP-Rac1 (1-188) (Q61L/S29S) and DWRC230 (consisting of Sra1, Nap1,
HSPC300, MBP-Abi2(1-158) and MBP-WAVE1(1–230)). Extra care was given when preparing the pro-
tein samples to ensure good data quality since the WRC is observed to be sensitive to denaturation,
likely caused by liquid surface tension from air bubbles and mechanical shaking, especially in the
absence of glycerol in the buffer. The sample preparation required gentle pipetting, avoiding air
bubbles or foaming, and removing sticky, denatured WRC floating on the surface after centrifuga-
tion steps prior to AUC analyses (same cautions were applied to all other experiments reported
here). Both the WRC and EGFP-Rac1 samples were passed through a Hiload Superdex 200 gel filtra-
tion column (GE Healthcare) equilibrated with 20 mM HEPES pH 7, 150 mM NaCl, 10 or 20% (w/v)
glycerol and 1 mM DTT (and 2 mM MgCl2 for EGFP-Rac1) to remove potential aggregates. The pro-
teins were aliquoted, flash frozen in liquid nitrogen, and stored at  80˚C. Before use, proteins were
thawed in a water bath at room temperature and subjected to extensive dialysis (for 3 continuous
days with multiple buffer exchanges at 4˚C) in the same beaker containing AUC buffer (10 mM
HEPES pH 7, 100 mM NaCl, 2 mM MgCl2, and 1 mM DTT) to remove glycerol (which could affect
the AUC interference signal) and to maximize buffer match. After dialysis, the samples were centri-
fuged at ~21,000 g for 10 min at 4˚C to remove denatured proteins. Approximately 400 mL of the
samples were introduced into the sample sectors of dual-sector Epon centerpieces that had been
placed between sapphire windows in a standard AUC cell. The reference sectors were filled with the
same volumes of AUC buffer. The cells were inserted into an An50Ti rotor and put under vacuum for
temperature equilibration for a minimum of 2 hr. Subsequently, centrifugation was commenced at
50,000 rpm. Data were acquired using both absorbance at 490 nm and interference optics. All
experiments were performed overnight at 20˚C. Interferometric molar signal increments for the two
protein species were calculated based on their respective amino-acid compositions (Zhao et al.,
2011), resulting in 141,801 fringes M 1cm 1 for EGFP-Rac1 and 904,251 fringes M 1cm 1 for the
WRC. Using the former value as a standard, the data sets for EGFP-Rac1 alone were globally ana-
lyzed to establish its sedimentation coefficient and the extinction coefficient (Padrick et al., 2010) at
490 nm (32,310.8 AU M 1cm 1. This value is lower than the reported value of 56,000 AU M 1cm 1
(Cranfill et al., 2016), likely due to incomplete maturation of the EGFP tag during overnight expres-
sion (Heim et al., 1995). A data set for WRC alone was analyzed using only interference data to
determine its sedimentation coefficient. The actual concentrations of each protein species in the
assembled cells were calculated by integrating the ck(s) distributions as described below.
The MSSV data were analyzed using SEDPHAT (Balbo et al., 2005). Using the extinction coeffi-
cients obtained above, the interferometric and absorbance (at 490 nm) data from mixtures of the
WRC and EGFP-Rac1 were globally analyzed to yield component ck(s) distributions that reported on
the concentrations of WRC and EGFP-Rac1 as a function of sedimentation coefficient. By integrating
these distributions over sedimentation coefficient ranges where co-sedimentation was evident, the
concentrations of the individual proteins in the complex could be calculated, and thus the molar
ratios of the complexed WRC and EGFP-Rac1 were derived. Sedimentation coefficient values for the
individual proteins and complexes were determined by a weighted integration scheme
(Schuck, 2003), yielding signal-average sedimentation coefficients. In combination with the
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calculated molar ratios and refined frictional ratios (Padrick et al., 2010), these values allow the
determination of the stoichiometries of the complexes.
Pyrene-actin assembly assay
Actin polymerization assays were performed at 22˚C using a PTI Fluorometer (Photon Technology
International) as previously described (Chen et al., 2014a). Reactions contained 4 mM actin (5% pyr-
ene labeled), 10 nM Arp2/3 complex, 100 nM WRC217VCA (Figure 1—figure supplement 1c; con-
sisting of Sra1, Nap1, HSPC300, Abi2(1-158) and WAVE1(1–217)-(GGS)6-(485-559)) or WRC230VCA
(Figure 6; consisting of Sra1, Nap1, HSPC300, Abi2(1-158) and WAVE1(1–230)-(GGS)6-(485-559)) or
VCA, and various amounts of Rac1 Q61L loaded with GMPPNP.
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